BRPI0412832A - uso terapêutico das yessotoxinas como inibidores do crescimento de células tumorais humanas - Google Patents

uso terapêutico das yessotoxinas como inibidores do crescimento de células tumorais humanas

Info

Publication number
BRPI0412832A
BRPI0412832A BRPI0412832-0A BRPI0412832A BRPI0412832A BR PI0412832 A BRPI0412832 A BR PI0412832A BR PI0412832 A BRPI0412832 A BR PI0412832A BR PI0412832 A BRPI0412832 A BR PI0412832A
Authority
BR
Brazil
Prior art keywords
yessotoxins
inhibitors
cell growth
tumor cell
therapeutic use
Prior art date
Application number
BRPI0412832-0A
Other languages
English (en)
Inventor
Luis Miguel Botana Lopez
Alfonso Rancaño Amparo
Maria Jose Pazoz Guldris
Mercedes Rodriguez Vieytes
Maria Isabel Loza Garcia
Juan Manuel Vieites Bapt Sousa
Original Assignee
Univ Santiago Compostela
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Santiago Compostela filed Critical Univ Santiago Compostela
Publication of BRPI0412832A publication Critical patent/BRPI0412832A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

"USO TERAPêUTICO DAS YESSOTOXINAS COMO INIBIDORES DO CRESCIMENTO DE CéLULAS TUMORAIS HUMANAS". O Uso terapêutico das yessotoxinas como inibidores do crescimento de células tumorais humanas. O mecanismo de ação da yessotoxina (YTX) e de análogos está relacionado à ativação das fosfodiesterases celulares e, como conseqüência, à diminuição dos níveis citossólicos de AMPc. O resultado desta ativação, depois da administração de YTX, é uma inibição do crescimento de células de hepatocarcinoma humano. Este efeito citotóxico da YTX sobre células neoplásicas pode ser utilizado como estratégia para o desenvolvimento de fármacos úteis no tratamento de processos tumorais.
BRPI0412832-0A 2003-07-25 2004-07-21 uso terapêutico das yessotoxinas como inibidores do crescimento de células tumorais humanas BRPI0412832A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200301773A ES2235611B2 (es) 2003-07-25 2003-07-25 Metodo cuantitativo para la deteccion de yesotoxinas en productos pesqueros basado en la activacion que producen en las fosfodiesterasas.
PCT/ES2004/000343 WO2005012543A2 (es) 2003-07-25 2004-07-21 Método cuantitativo para la detección de yesotoxinas en productos pesqueros basado en la activación que la toxina produce en las fosfodiesterasas celulares y utilidad terapéutica de esta activación.

Publications (1)

Publication Number Publication Date
BRPI0412832A true BRPI0412832A (pt) 2006-11-21

Family

ID=34112518

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0412832-0A BRPI0412832A (pt) 2003-07-25 2004-07-21 uso terapêutico das yessotoxinas como inibidores do crescimento de células tumorais humanas

Country Status (12)

Country Link
US (1) US20110065138A1 (pt)
EP (3) EP1875907B1 (pt)
JP (2) JP2006528483A (pt)
CN (1) CN1852988A (pt)
AT (3) ATE524174T1 (pt)
AU (3) AU2004260895A1 (pt)
BR (1) BRPI0412832A (pt)
CA (1) CA2533600A1 (pt)
DE (1) DE602004013446D1 (pt)
ES (4) ES2235611B2 (pt)
RU (1) RU2389488C2 (pt)
WO (1) WO2005012543A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101382531B (zh) * 2008-10-08 2011-12-28 天津商业大学 利用电子鼻检测虾新鲜度的方法
ES2393696B2 (es) * 2012-09-07 2013-06-04 Universidade De Santiago De Compostela Uso de la Yessotoxina y sus derivados para el tratamiento de gliomas
CN105198900A (zh) * 2015-09-22 2015-12-30 国家海洋环境检测中心 虾夷扇贝毒素ytx纯品的提取、制备方法
US10890573B2 (en) 2017-12-19 2021-01-12 International Business Machines Corporation Facile methods to detect toxin in seafood
RU2716233C1 (ru) * 2018-11-13 2020-03-10 Федеральное государственное бюджетное учреждение науки "Федеральный исследовательский центр питания, биотехнологии и безопасности пищи" Способ количественного определения йессотоксинов в моллюсках

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672509A (en) * 1993-08-25 1997-09-30 Pfizer Inc. hPDE IV-C: a human phosphodiesterase IV isozyme
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
AU3635099A (en) * 1997-12-15 1999-07-26 Beth Israel Deaconess Medical Center Methods and reagents for modulating cell motility
IT1318605B1 (it) 2000-06-30 2003-08-27 Uni Degli Studi Di Modena E Re Procedimoento per il dosaggio di tossine dsp del gruppo delledinophysitossine e delle yessottossine.
US6977155B2 (en) * 2000-08-10 2005-12-20 Corning Incorporated Arrays of biological membranes and methods and use thereof
EP1251181A1 (en) * 2001-04-20 2002-10-23 Warner-Lambert Company Non-recombinant cell lines capable of expressing predominantly cyclic nucleotide phosphodiesterase 4 (PDE4) subtype B and their use for the screening of PDE4 subtype-specific modulators

Also Published As

Publication number Publication date
EP1647599B1 (en) 2008-04-30
JP2006325580A (ja) 2006-12-07
EP1875907A2 (en) 2008-01-09
JP2006528483A (ja) 2006-12-21
CN1852988A (zh) 2006-10-25
EP1875906A2 (en) 2008-01-09
ES2259894B2 (es) 2008-11-16
ES2259894A1 (es) 2006-10-16
ES2368872T3 (es) 2011-11-23
EP1875906A3 (en) 2008-02-27
US20110065138A1 (en) 2011-03-17
ATE524174T1 (de) 2011-09-15
WO2005012543A2 (es) 2005-02-10
EP1875906B1 (en) 2011-06-29
AU2010202237A1 (en) 2010-06-24
RU2389488C2 (ru) 2010-05-20
AU2010202232A1 (en) 2010-07-08
DE602004013446D1 (de) 2008-06-12
CA2533600A1 (en) 2005-02-10
ES2259266A1 (es) 2006-09-16
EP1875907A3 (en) 2008-02-27
RU2006101631A (ru) 2006-08-27
ES2259266B2 (es) 2008-06-01
ATE393833T1 (de) 2008-05-15
ES2235611B2 (es) 2006-07-16
EP1875907B1 (en) 2011-09-14
ATE514423T1 (de) 2011-07-15
WO2005012543A3 (es) 2005-03-17
EP1647599A2 (en) 2006-04-19
ES2235611A1 (es) 2005-07-01
AU2004260895A1 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
TR201903587T4 (tr) Telomeraz aktivitesinin artırılması için bileşimler.
EA200700407A1 (ru) Производные хиназолина и их использования при лечении тромбоцитемии
DK1496895T3 (da) Anvendelse af cyclopamin til behandling af psoriasis og andre hudlidelser
NO20072548L (no) Xantinderivater med HM74A reseptoraktivitet
BRPI0412314B8 (pt) composto 3-[2(r)-{hidroxicarbonilpropil-amino}-2-feniletil]-5-(2-flúor-3-metoxifenil)-1-[2-flúor-6-(trifluorometil)benzil]-6-metil-pirimidina-2,4(1h,3h)-diona, composição farmacêutica compreendendo dito composto e uso do mesmo para o tratamento de uma condição relacionada ao hormônio sexual
DE602005009318D1 (de) Kondensierte heteroyralderivate zur verwendung als p38-kinase-inhibitoren
AR071609A1 (es) Inhibidores ciclicos de 11(beta) -hidroxiesteroide deshidrogenasa 1
CU23423B7 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulación sanguínea
EA200601747A1 (ru) Три(цикло)замещённые амидные соединения
DE50208008D1 (de) Tiotropiumsalze zur behandlung von entzündlichen erkrankungen
NO20064365L (no) Terapeutisk forbindelse
UY27872A1 (es) Inhibidores de caspasa y usos de los mismos.
WO2002091999A3 (en) Treatment for wounds
EA200970110A1 (ru) Производные 6,9-дизамещённого пурина и их применение для лечения кожи
NO20083005L (no) Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av smerte
ATE413392T1 (de) Kondensierte heteroyralderivate und deren verwendung als p38-kinase-inhibitoren
EA200970294A1 (ru) Способ наращивания стволовых клеток взрослого организма из крови, в частности периферической, и соответственное применение в области медицины
CY1109763T1 (el) Υλικα και μεθοδος για τη θεραπεια διαταραχων πηξης
NO20041059L (no) Kombinasjon av utvalgte opioder med muskarinantagonister for behandling av urininkontinens
DE602006011959D1 (de) Na+, k+-atpase-expression bei zervixdysplasie und -krebs
ATE556134T1 (de) Mesenchymstammzellen und verwendungendafür
BRPI0412832A (pt) uso terapêutico das yessotoxinas como inibidores do crescimento de células tumorais humanas
BR112012016128A8 (pt) Agente terapêutico (y-39983) para disfunção endotelial da córnea
BRPI0511125A (pt) usos de ácido 5,6,7-triidroxieptanóico seus e análogos
EA200600468A1 (ru) Биполярные транс-каротиноидные соли и их применение

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]